H2BC3 is a core histone protein that functions as a structural component of nucleosomes, the fundamental units of chr6 organization 1. As part of the nucleosome, H2BC3 wraps DNA and regulates chr6 compaction, thereby controlling DNA accessibility for transcription, replication, and repair processes. Post-translational modifications of H2BC3 and nucleosome remodeling contribute to the histone code that fine-tunes gene regulation 1. Clinically, H2BC3 has emerged as a disease-relevant biomarker. In preclinical Alzheimer's disease, elevated expression of a chromosome 6 histone gene cluster module—featuring H2BC3 as a key component—is associated with lower brain amyloid burden in cognitively unimpaired individuals 1. This suggests H2BC3 expression may reflect protective mechanisms against amyloid accumulation. Additionally, H2BC3 appears in protein interaction networks dysregulated in colon adenocarcinoma, where it exhibits elevated connectivity in disease-associated gene regulatory pathways 2. These findings indicate H2BC3 has potential value as a blood-based biomarker for neurodegenerative and neoplastic disease progression, though mechanistic details of its involvement in disease pathogenesis require further investigation.